Development and ELISA Characterization of Antibodies against the Colistin, Vancomycin, Daptomycin, and Meropenem: A Therapeutic Drug Monitoring Approach

• Autori principali: Vivian Garzon (Autore), J.-Pablo Salvador (Autore), M.-Pilar Marco (Autore), Daniel G.-Pinacho (Autore), Rosa-Helena Bustos (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2024-06-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

More than 70% of bacteria are resistant to all or nearly all known antimicrobials, creating the need for the development of new types of antimicrobials or the use of "last-line" antimicrobial therapies for the treatment of multi-resistant bacteria. These antibiotics include Glycopeptide (V...